The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).
Explore this paper's citation graph
Summary
A revised version of the ALSFRS, which incorporates additional assessments of dyspnea, orthopnea, and the need for ventilatory support is validated, indicating that the quality of function is a strong determinant of quality of life in ALS.
- Type
- article
- Published
- 1999-10-31
- Cited by
- 3,158
- References
- 25
- OpenAlex
- https://openalex.org/W2108381339
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:7057926
Keywords
Rating scale, Quality of life (healthcare), Physical medicine and rehabilitation, Physical therapy, Amyotrophic lateral sclerosis
References
- Respiratory dysfunction in amyotrophic lateral sclerosis.
- Principles of test theories
- The Sickness Impact Profile: Development and Final Revision of a Health Status Measure
- Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential.
- A method of scaling psychological and educational tests.
- The Journal of the Neurological Sciences
- Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials.
- Neurological effects of microwave exposure related to mobile communication.
- A controlled trial of recombinant methionyl human BDNF in ALS
- The Amyotrophic Lateral Sclerosis Functional Rating Scale
- Regression Models and Life-Tables
Cited by
- Noninvasive Ventilation Improves Sleep in Amyotrophic Lateral Sclerosis: A Prospective Polysomnographic Study
- [Cough and neuromuscular diseases. Noninvasive airway secretion management].
- Measurement of decline of functioning in persons with amyotrophic lateral sclerosis: Responsiveness and possible applications of the Functional Independence Measure, Barthel Index, Rehabilitation Activities Profile and Frenchay Activities Index
- Quantitative objective markers for upper and lower motor neuron dysfunction in ALS
- Clinical characteristics of familial amyotrophic lateral sclerosis with a Phe20Cys mutation in the SOD1 gene in a Korean family
- Phase 2 study of sodium phenylbutyrate in ALS
- Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
- Differences in quality of life modalities give rise to needs of individual support in patients with ALS and their next of kin
- Burden, depression, and anxiety in caregivers of people with amyotrophic lateral sclerosis
- Differential corticospinal tract degeneration in homozygous ‘D90A’ SOD-1 ALS and sporadic ALS
- Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm
- Progression of white matter degeneration in amyotrophic lateral sclerosis: A diffusion tensor imaging study
- The Department of Veterans Affairs Biorepository Brain Bank: A national resource for amyotrophic lateral sclerosis research
- CSF cytokine profile distinguishes multifocal motor neuropathy from progressive muscular atrophy
- Measuring the validation of assessing the non-dominant-hand function by ALSFRS-r in Chinese ALS patients.
- Investigating the neuroanatomical substrate of pathological laughing and crying in amyotrophic lateral sclerosis with multimodal neuroimaging techniques
- Exploring reasons for declining and withdrawing from non-invasive ventilation among motor neurone disease patients: an interpretative phenomenological analysis
- Spinal excitability changes do not influence the mechanisms of split‐hand syndrome in amyotrophic lateral sclerosis
- New insights into the pathophysiology of fasciculations in amyotrophic lateral sclerosis: An ultrasound study.
- SVC Is a Marker of Respiratory Decline Function, Similar to FVC, in Patients With ALS
Related papers
- Genetics of Amyotrophic Lateral Sclerosis
- OUP accepted manuscript
- Amyotrophic lateral sclerosis sera applied to cultured motor neurons.
- Diagnosis and Treatment of Amyotrophic Lateral Sclerosis
- Targeting Macrophage for the Treatment of Amyotrophic Lateral Sclerosis.
- Pathological mechanisms of amyotrophic lateral sclerosis
- ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
- Spinal fluid cells and protein in amyotrophic lateral sclerosis.
- Riluzole for amyotrophic lateral sclerosis.